Related Experiment Video

Updated: Apr 20, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.8K

Compassionate use of experimental drugs in the Ebola outbreak - Authors' reply

Annette Rid1, Ezekiel J Emanuel2

  • 1Department of Social Science, Health & Medicine, King's College London, London WC2R 2LS, UK.

Lancet (London, England)
|December 3, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K
Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment
08:22

Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment

Published on: July 19, 2017

10.9K

Related Experiment Videos

Last Updated: Apr 20, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.8K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K
Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment
08:22

Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment

Published on: July 19, 2017

10.9K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

34.1K
Overview
34.1K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

418
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
418

Articles linked to this work by shared authors, journal, and citation graph.

Streamlining oversight in Medicare advantage: measuring coding intensity via contract rankings.

Health affairs scholar·2026

The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments.

EClinicalMedicine·2026

The Enduring Promise of Personalising Patient Preference Prediction.

Neuroethics·2026

A randomized control trial of re-designed and shorter research informed consent forms to improve comprehension.

Clinical trials (London, England)·2026

A Machine Learning Model to Improve Risk Adjustment Accuracy in Medicare.

Health services research·2026

The paradox of trust in health care in the age of social media.

Lancet (London, England)·2026

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Eco-anxiety, Psychology, and Theological Beliefs About Creation Among Clergy and Lay People in the Church of England.

Journal of religion and health·2026

Correction: Nurturing a sustainable transplantation journey: the best of ESOT congress 2025.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Ethical evaluation of AI-supported mental health applications.

Frontiers in psychiatry·2026

Uncertainty and novel clinical trial designs in oncology - when should equipoise matter?

Clinical trials (London, England)·2026

Non-complicity as a principle of public health ethics.

Public health ethics·2026

New oncology trial designs and equipoise: Commentary on Heynemann et al.

Clinical trials (London, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us